CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,829,038
+61.3%
591,849
+43.4%
0.00%0.0%
Q2 2023$1,753,656
-19.5%
412,625
+0.5%
0.00%0.0%
Q1 2023$2,179,484
-14.3%
410,449
+1.4%
0.00%0.0%
Q4 2022$2,542,785
-39.6%
404,902
+1.6%
0.00%
-50.0%
Q3 2022$4,207,000
+273.6%
398,711
+92.4%
0.00%
Q2 2022$1,126,000
-42.8%
207,219
-3.4%
0.00%
-100.0%
Q1 2022$1,970,000
-8.4%
214,545
+50.5%
0.00%0.0%
Q4 2021$2,151,000
-32.4%
142,516
+6.9%
0.00%0.0%
Q3 2021$3,182,000133,2770.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,266,04015.18%
Elmwood Wealth Management, Inc. 2,364,415$11,301,9045.45%
PFM Health Sciences, LP 6,724,715$32,144,1381.51%
SILVERARC CAPITAL MANAGEMENT, LLC 892,786$4,267,5171.29%
Avidity Partners Management LP 6,050,212$28,920,0131.16%
Paradigm Biocapital Advisors LP 2,944,513$14,074,7720.96%
Kynam Capital Management, LP 1,068,527$5,107,5590.84%
Green Alpha Advisors, LLC 110,524$528,3050.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,500,000$16,730,0000.37%
Bruce & Co., Inc. 200,000$956,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders